<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="resptable5" position="float"><label>Author response table 5.</label><caption><title>List of available class B GPCRs structures.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Receptor</th><th>PDB code</th><th>Method</th><th>Resolution (&#197;)</th><th>Ligand + G protein/G protein memetic</th><th valign="top">States</th></tr></thead><tbody><tr><td>CRF1R</td><td>4K5Y</td><td>X-ray</td><td>2.9</td><td>Antagonist CP-376395</td><td valign="top">Inactive</td></tr><tr><td>CRF1R</td><td>4Z9G</td><td>X-ray</td><td>3.2</td><td>Antagonist CP-376395</td><td valign="top">Inactive</td></tr><tr><td>CTR</td><td>6NIY</td><td>cryo-EM</td><td>3.3</td><td>Peptide ligand + G<sub>s</sub></td><td valign="top">Active</td></tr><tr><td>CTR</td><td>5UZ7</td><td>cryo-EM</td><td>4.1</td><td>Peptide ligand + G<sub>s</sub></td><td valign="top">Active</td></tr><tr><td>CGRP</td><td>6E3Y</td><td>cryo-EM</td><td>3.3</td><td>CGRP + G<sub>s</sub></td><td valign="top">Active</td></tr><tr><td>GCGR</td><td>4L6R</td><td>X-ray</td><td>3.3</td><td>No ligand was seen</td><td valign="top">Inactive</td></tr><tr><td>GCGR</td><td>5EE7</td><td>X-ray</td><td>2.5</td><td>Antagonist MK-0893</td><td valign="top">Inactive</td></tr><tr><td>GCGR</td><td>5YQZ</td><td>X-ray</td><td>3.0</td><td>Partial agonist NNC1702</td><td valign="top">Intermediate</td></tr><tr><td>GCGR</td><td>5XEZ</td><td>X-ray</td><td>3.0</td><td>Negative allosteric modulator NNC0640</td><td valign="top">Inactive</td></tr><tr><td>GCGR</td><td>5XF1</td><td>X-ray</td><td>3.2</td><td>Negative allosteric modulator NNC0640</td><td valign="top">Inactive</td></tr><tr><td>GLP-1R</td><td>5VAI</td><td>cryo-EM</td><td>4.1</td><td>human GLP-1 + G<sub>s</sub></td><td valign="top">Active</td></tr><tr><td valign="top">GLP-1R</td><td>6B3J</td><td>cryo-EM</td><td>3.3</td><td>Exendin-P5 + G<sub>s</sub></td><td valign="top">Active</td></tr><tr><td valign="top">GLP-1R</td><td>5NX2</td><td valign="top">X-ray</td><td>3.7</td><td>Truncated peptide agonist</td><td valign="top">Intermediate</td></tr><tr><td valign="top">GLP-1R</td><td>5VEW</td><td valign="top">X-ray</td><td>2.7</td><td>PF-06372222</td><td valign="top">Inactive</td></tr><tr><td valign="top">GLP-1R</td><td>5VEX</td><td valign="top">X-ray</td><td>3.0</td><td>NNC0640</td><td valign="top">Inactive</td></tr><tr><td>PTH1R</td><td>6FJ3</td><td>X-ray</td><td>2.5</td><td>Peptide agonist ePTH</td><td valign="top">Intermediate</td></tr><tr><td>PTH1R</td><td>6NBH</td><td valign="top">cryo-EM</td><td>3.5</td><td>A long-acting PTH analog + G<sub>s</sub></td><td valign="top">Active</td></tr><tr><td>PTH1R</td><td>6NBI</td><td valign="top">cryo-EM</td><td>4.0</td><td>A long-acting PTH analog + G<sub>s</sub></td><td valign="top">Active</td></tr><tr><td>PTH1R</td><td>6NBF</td><td valign="top">cryo-EM</td><td>3.0</td><td>A long-acting PTH analog + G<sub>s</sub></td><td valign="top">Active</td></tr></tbody></table></table-wrap>